(MENAFN- Straits Research)
Cannabis Testing Market Size & Growth Analysis
The global cannabis testing market size was valued at USD 1.28 billion in 2025 and is projected to grow from USD 1.45 billion in 2026 to USD 4.02 billion by 2034, registering a CAGR of 13.55% during the forecast period from 2026 to 2034. North America dominated the cannabis testing market with a market share of 46.5% in 2025.
Cannabis testing refers to the laboratory analysis of cannabis plants, extracts, and finished products to verify their quality, safety, and potency. It involves testing for cannabinoids, terpenes, pesticides, heavy metals, residual solvents, microbial contaminants, and moisture content. Cannabis testing helps producers meet regulatory standards, ensures product consistency, and provides consumers with safe, accurately labelled products for medical and recreational use.
Cannabis Testing Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 1.28 Billion
2026 Market Size: USD 1.45 Billion
2034 Projected Market Size: USD 4.02 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 13.55%
Regional Insights
Largest Regional Market (2025): North America
North America Share (2025): 46.5%
Fastest-Growing Region: Europe
Europe CAGR (2026–2034): 14.6%
Segment Insights
By Test Type
Leading Segment: Microbial Analysis, Potency Testing
Market Share in 2025: 61.3%
By End-User
Fastest-growing segment: Cannabis Drug Manufacturers
CAGR: 12.9% (2026-2034)
Download a Free Sample To learn more about this report,
Cannabis Testing Market Trends
Growing Adoption of High-Precision Analytical Methods for Cannabis Testing
The market is moving toward more precise analytical workflows as laboratories need to distinguish closely related cannabinoids and produce reliable potency measurements. Chromatographic methods are increasingly being refined to reduce analytical interference and improve the accuracy of cannabinoid quantification, particularly where regulatory thresholds depend on precise measurements. This is increasing the need for validated analytical procedures and advanced laboratory capabilities.
In March 2025, NIST published research identifying chromatographic interferences that can artificially increase measured Δ9-THC levels in cannabis samples and evaluated approaches to improve measurement accuracy.
Increasing Focus on Comprehensive Contaminant and Quality Testing
Cannabis testing is increasingly covering multiple quality and safety parameters rather than focusing only on cannabinoid potency. Regulatory testing frameworks include pesticides, heavy metals, microbial impurities, mycotoxins, residual solvents, moisture, and foreign material, requiring laboratories to maintain broader analytical capabilities and quality-control procedures.
In April 2025, California's Department of Cannabis Control regulations required licensed laboratories to test representative cannabis samples for cannabinoids, foreign material, heavy metals, microbial impurities, mycotoxins, residual pesticides, residual solvents, and other specified parameters.
Cannabis Testing Market Dynamics
Market Drivers
Mandatory Batch Testing Requirements Increase Demand for Cannabis Laboratory Services
Regulated cannabis markets require laboratory verification before products can be released for sale. Testing provides producers and regulators with evidence that products meet specified potency and contaminant requirements, creating recurring demand for accredited analytical laboratories and specialized testing services as regulated production expands.
In July 2026, California's Department of Cannabis Control stated that every batch of cannabis goods must be tested before sale, covering cannabinoids and terpenes as well as chemical, microbial, and physical contaminants.
Market Restraints
Complex Method Validation Requirements Increase Laboratory Operating Costs
Cannabis laboratories must validate analytical methods, maintain calibration and quality-control records, use appropriate reference materials, and demonstrate reliable measurement performance. These requirements increase the technical resources needed to establish and maintain testing capabilities, particularly for laboratories handling multiple analytes and product types.
In June 2025, California's laboratory regulations required validation reports to document calibration data, raw data, reference-material results, detection and quantification limits, and laboratory quality-control information for testing methods.
Market Opportunities
Expansion of Interlaboratory Quality Programs Creates Demand for Measurement-Standardization Solutions
The need for comparable laboratory results creates opportunities for reference materials, analytical quality-assurance programs, method-development services, and technologies that improve measurement consistency. Standardized measurement practices can help laboratories reduce variability and provide regulators and producers with greater confidence in reported cannabis test results.
In April 2025, NIST published results from its Cannabis Laboratory Quality Assurance Program's moisture exercise, reporting wide variation among participating laboratories and identifying the need for consistent drying methods for accurate and precise measurements.
Market Challenges
Evolving Pesticide Requirements Increase Testing Complexity for Cannabis Laboratories
Changes in permissible pesticide levels and laboratory quantification requirements can require testing facilities to modify analytical methods, detection capabilities, and reporting procedures. Laboratories must therefore keep their testing protocols aligned with regulatory changes while maintaining reliable results across different cannabis products.
In July 2026, California approved revised pesticide-testing regulations that update pesticide action levels and laboratory limit-of-quantitation requirements, with the changes scheduled to take effect in October 2026.
Cannabis Testing Market Segmentation
By Test Type
Microbial Analysis & Potency Testing accounted for the largest share of the global cannabis testing market at 61.3% in 2025, driven by stringent regulatory requirements for contaminant screening and cannabinoid potency verification. The increasing legalization of medical and recreational cannabis, coupled with growing consumer demand for safe, accurately labeled, and high-quality cannabis products, continues to support the dominance of this segment. Meanwhile, heavy metal testing remains an essential part of cannabis quality assurance, helping manufacturers detect toxic contaminants and comply with product safety regulations.
Request Customization to receive a tailored report.
By End-User
The Cannabis Drug Manufacturers segment is projected to expand at the highest CAGR of 12.9% during 2026–2034, supported by rising investments in cannabis-derived pharmaceuticals, increasing clinical research activities, and growing regulatory requirements for product quality and safety. The expanding pipeline of cannabis-based therapeutics is further driving the demand for advanced cannabis testing services. At the same time, cannabis cultivators continue to represent a significant end-user group, relying on testing services to ensure crop quality, detect contaminants, and meet cultivation and distribution standards.
Speak to an Analyst to discuss market opportunities.
Cannabis Testing Market Regional Analysis
North America Cannabis Testing Market Analysis
North America dominated the global cannabis testing market with a 46.5% market share, valued at USD 0.60 billion in 2025. The region benefits from the widespread legalization of medical and recreational cannabis, stringent product quality regulations, and a well-established network of accredited testing laboratories. Strong adoption of advanced analytical technologies, including chromatography and mass spectrometry, along with increasing consumer demand for safe and compliant cannabis products, continues to support market growth.
United States Cannabis Testing Market Insights
The United States accounted for an estimated USD 0.48 billion of the market in 2025, making it the largest contributor in North America. Growth is driven by expanding state-level cannabis legalization, mandatory laboratory testing requirements, and increasing demand for potency and contaminant analysis. The presence of leading cannabis testing laboratories and analytical instrument manufacturers further strengthens the country's market position.
Canada Cannabis Testing Market Insights
Canada generated an estimated USD 0.12 billion in 2025. The country's market is supported by nationwide cannabis legalization, strict regulatory oversight by Health Canada, and increasing demand for standardized testing to ensure product quality, potency, and consumer safety across medical and recreational cannabis products.
Unlock Regional Insights to access country-level data, & regional trends.
Europe Cannabis Testing Market Analysis
Europe accounted for 27.3% of the global cannabis testing market, reaching USD 0.35 billion in 2025, and is projected to register the fastest CAGR of 14.6% during the forecast period. The market is driven by expanding medical cannabis legalization, increasing pharmaceutical research involving cannabis-derived therapies, and strengthening quality standards for cannabis products. Growing investments in laboratory infrastructure and regulatory compliance continue to accelerate regional market growth.
United Kingdom Cannabis Testing Market Insights
The United Kingdom represented an estimated USD 0.10 billion in 2025. The country's market is driven by growing clinical research on cannabis-based medicines, increasing regulatory oversight, and rising investments in laboratory testing to ensure pharmaceutical-grade cannabis quality and safety.
Germany Cannabis Testing Market Insights
Germany led the European market with an estimated value of USD 0.13 billion in 2025. Growth is supported by the country's expanding medical cannabis industry, increasing patient access following regulatory reforms, and rising demand for laboratory testing to comply with pharmaceutical quality standards.
Asia Pacific Cannabis Testing Market Analysis
Asia Pacific accounted for 16.2% of the global cannabis testing market, valued at USD 0.21 billion in 2025. The regional market is driven by increasing research on cannabis-derived medicines, expanding biotechnology capabilities, and gradual regulatory developments supporting medical cannabis in selected countries. Growing investments in laboratory infrastructure and analytical technologies are expected to further strengthen market growth.
Japan Cannabis Testing Market Insights
Japan generated an estimated USD 0.05 billion in 2025. The country's market is supported by increasing research into cannabinoid-based therapeutics, stringent pharmaceutical quality requirements, and growing investments in advanced analytical testing technologies.
China Cannabis Testing Market Insights
China accounted for an estimated USD 0.09 billion in 2025, making it the largest market in Asia Pacific. The country's strong analytical instrument manufacturing capabilities, expanding pharmaceutical research activities, and increasing focus on cannabis-derived medical applications continue to drive market growth.
Middle East & Africa Cannabis Testing Market Analysis
The Middle East & Africa represented 3.9% of the global cannabis testing market, totaling USD 0.05 billion in 2025. Market growth is supported by increasing investments in healthcare infrastructure, growing interest in cannabis-based pharmaceutical research, and expanding laboratory capabilities to meet international quality and safety standards.
UAE Cannabis Testing Market Insights
The United Arab Emirates (UAE) accounted for an estimated USD 0.02 billion in 2025. The market is driven by increasing investments in life sciences, expanding pharmaceutical research infrastructure, and growing adoption of advanced laboratory technologies to support regulated medical applications.
Africa Cannabis Testing Market Insights
Africa is witnessing steady growth in the cannabis testing market, supported by the expansion of medical cannabis cultivation, increasing regulatory oversight, and rising investments in laboratory infrastructure. Countries such as South Africa, Lesotho, and Zimbabwe are strengthening quality assurance practices for cannabis production, creating long-term opportunities for cannabis testing service providers and analytical equipment manufacturers.
List of Key and Emerging Players in Cannabis Testing Market
Agilent Technologies Inc.
Danaher Corporation
MERCK KGAA
Perkin Elmer
Restek Corporation
SC Laboratories
Shimadzu Corporation
Steep Hill
Key Industry Developments
July 2026: Agilent Technologies introduced an expanded cannabis testing workflow featuring enhanced LC/MS and GC/MS analytical solutions for potency, pesticide, and contaminant testing. The platform improves laboratory efficiency and regulatory compliance.
May 2026: Shimadzu Corporation launched new cannabis testing methods for residual solvents and cannabinoid profiling, enabling testing laboratories to improve analytical accuracy and throughput.
March 2026: PerkinElmer expanded its cannabis quality testing portfolio with automated analytical solutions for heavy metals, mycotoxins, and terpene analysis, supporting evolving regulatory requirements.
September 2025: Waters Corporation introduced validated cannabis testing workflows for HPLC and mass spectrometry platforms, helping laboratories streamline compliance testing and quality assurance.
Report Scope
Comments
No comment